| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $693.4M | +30.4% |
| R&D Expense | $149.3M | +65.3% |
| SG&A Expense | $755.4M | +154.5% |
| Operating Income | -$691.1M | -252.4% |
| Interest Expense | $53.7M | +14.5% |
| Pre-tax Income | -$701.3M | -228.4% |
| Income Tax | $266K | -7.6% |
| Net Income | -$705.8M | -229.6% |
| EPS (Basic) | -$6.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $341.0M | +105.7% |
| Accounts Receivable | $154.8M | +63.9% |
| Inventory | $38.4M | +33.1% |
| Current Assets | $667.6M | +90.6% |
| Total Assets | $926.1M | +64.2% |
| Current Liabilities | $291.1M | +25.1% |
| Total Liabilities | $869.8M | +3.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$189.0M | +11.8% |
| Capital Expenditures | $22.1M | -36.1% |
| Investing Cash Flow | -$130.4M | -223.4% |
| Financing Cash Flow | $494.3M | +320.5% |
| Free Cash Flow | -$211.2M | +15.2% |
| -48.3% |
| EPS (Diluted) | -$6.23 | -48.3% |
| Stockholders' Equity |
| $56.3M |
| +104.1% |